AbioCor®

Impella 2.5

The AbioCor is the world’s first completely self-contained replacement heart. A product of three decades of research, development and testing, the AbioCor is central to ABIOMED’s mission to make real the day when heart failure need not mean the end of life or the ability to enjoy life. Designed to fully sustain the body’s circulatory system, the AbioCor is intended for end-stage heart failure patients whose other treatment options have been exhausted.

How It Works

As one of the most sophisticated implantable medical devices to be developed, the AbioCor is designed so that a patient can remain mobile and continue a productive lifestyle. Equipped with an internal motor, the AbioCor is able to move blood through the lungs and to the rest of the body, simulating the rhythm of a heartbeat. The AbioCor consists of an internal thoracic unit, an internal rechargeable battery, an internal miniaturized electronics package and an external battery pack.
See how it works.

AbioCor System

The AbioCor System is designed for use by patients who have irreparably damaged hearts or who are at risk of imminent death as a result of end-stage heart failure that cannot be treated by optimal medical treatment.

Quick Facts

  • Mimics function of the native heart
  • Destination device
  • No wires cross the skin

Patient Specifications

The AbioCor is indicated for use in severe biventricular end stage heart disease patients who are not cardiac transplant candidates and who:

  • are less than 75 years old,
  • require multiple inotropic support,
  • are not treatable by LVAD destination therapy, and
  • are not weanable from biventricular support if on such support.
« back to top

World's First Artificial Heart

abiocor
AbioCor Patient

In September 2001, Tom Christerson become the second man to be fitted with the Abiocor Total Artificial Heart at Jewish Hospital in Louisville, Kentucky. Tom, age 70 at the time of the surgery, was a resident of Kentucky, and ran a business selling tires to the coal mining community. At the time of his surgery, Tom was given less than a 20 percent chance of surviving 30 days. Just days after the operation, Tom was breathing on his own and sitting up in a chair. He was removed from ventilator support the next day following surgery.

By February 2002, Tom was able to walk without effort or any type of assistive device, another milestone in his incredible recovery. In April 2002, Tom was discharged home to be with his family. Tom lived a total of 17 months with the AbioCor.

Download the
Abicor FAQs